Presentations Medicenna Therapeutics Corp. - Corporate Presentation June 2024 Sachs 10th Annual Oncology Innovation Forum Presentation Clinical Update from Phase 1/2 ABILITY Study National Brain Tumor Society's Research Round Table Presentation Past Events June 18, 2020 at 1:40 PM EDT Raymond James Human Healthcare Innovation Conference Go to June 9 - June 12, 2020 Spring Virtual Investor Summit (Virtual) Go to May 29 - May 31, 2020 In vitro and in vivo characteristics of MDNA11: A long-acting 'Beta-only' IL-2 Superkine in syngeneic mice tumor models and non-human primates Go to May 29 - May 31, 2020 MDNA55 survival in recurrent glioblastoma ("rGBM") patients expressing the interleukin-4 receptor ("IL4R") as compared to a matched synthetic control Go to March 26 - March 27, 2020 6th Annual Immuno-Oncology Innovation Forum (Virtual) Go to March 25, 2020 at 10:00 AM EDT IL-2 Superkine, MDNA19, Non-Human Primate Study Go to Pagination First page « first Previous page ‹ previous … Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Current page 13 Page 14 Next page next › Last page last »
May 29 - May 31, 2020 In vitro and in vivo characteristics of MDNA11: A long-acting 'Beta-only' IL-2 Superkine in syngeneic mice tumor models and non-human primates Go to
May 29 - May 31, 2020 MDNA55 survival in recurrent glioblastoma ("rGBM") patients expressing the interleukin-4 receptor ("IL4R") as compared to a matched synthetic control Go to
